Zika Vaccine Clinical Trial Begins

Media Coverage
Vials of Zika vaccine

BioPharm International

On Aug. 16, 2018, the National Institutes of Health (NIH) announced that vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH.

Read the Full Article